Advocacy intelligence hub — real-time data for patient organizations
Ministry of Health, Saudi Arabia — PHASE2
Mbarara University of Science and Technology — NA
Bahirdar University — NA
First Affiliated Hospital of Zhejiang University — PHASE4
Hamilton Health Sciences Corporation — PHASE3
Research Center Borstel
Riphah International University — NA
Obafemi Awolowo University Teaching Hospital — PHASE2
Nagasaki University
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance2
Priftin
(Rifapentine)Orphan drugHoechst Marion Roussel
Rifamycin Antimycobacterial [EPC]
12.1 Mechanism of Action Rifapentine, a cyclopentyl rifamycin, is an antimycobacterial agent [see Microbiology (12.4) ] .
Pranay Sinha, MD
Boston Medical Center
📍 BOSTON, MA
Rocco Trisolini, MD
Catholic University of the Sacred Hearth
Antonio Lombardi, MD
TB Alliance
Titus H Divala, MBBS MPH MS
London School of Hygiene and Tropical Medicine
Morounfolu Olugbosi, MD
Global Alliance for TB Drug Development
Grant Theron, PhD
University of Stellenbosch